INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 418m ago
House PTR17m ago
SEC 13F17m ago
Robinhood Chain17m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
RR
rahim ramiEVP, Pres GM Networking
HPEHewlett Packard Enterprise Co
Open-market sale · 10b5-1 plan
SELL$635K
10.9K sh
Oct 21, 2026Oct 23, 2026
Page 55 of 532
← PrevNext →
traded Oct 21, 2026
+2d
SEC Form 4

Evidence

11
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$746K
8,514 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$137K
563 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
WV
Walsh Paul V JrDirector
SMTCSEMTECH CORP
Open-market sale · 10b5-1 plan
SELL$70K
500 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$187K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
194 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,677 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$185K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
120 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
80 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

5
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$9,491
100 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$463K
2,728 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
60.0K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
RM
Rogers Daniel MarkDirector, Chief Executive Officer
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
19.7K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$376K
60.0K sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
60.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$267K
1,564 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$19K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$93K
552 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$154K
900 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$2,126
85 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

57
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale
SELL$1.16M
4,742 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

55
BP
Boswell PeytonDirector
LIQTLIQTECH INTERNATIONAL INC
Open-market purchase
BUY$50K
50.0K sh
Jun 5, 2026Oct 22, 2026
traded Jun 5, 2026
+139dSEC Form 4

Evidence

50
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale
SELL$270K
1,102 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
5,973 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
6,487 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$45K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

36
HB
Harrison David BenjaminPresident, Industries
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$1.82M
40.3K sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

34
KA
Kumar AmitDirector, Chief Executive Officer
ANIXAnixa Biosciences Inc
Open-market purchase
BUY$22K
8,000 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

34
MD
Monte Mark DavidDirector
NONENONEFundrise Real Estate Interval Fund, LLC
Open-market purchase
BUY$205
17 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

33
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$637K
3,538 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

32
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
5,514 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

32
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.08M
5,988 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

31
Saba Capital Management, L.P.10% Owner
LEOBNY MELLON STRATEGIC MUNICIPALS, INC.
Open-market purchase
BUY$263K
45.8K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

31
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Open-market sale
SELL$496K
12.8K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

31
Saba Capital Management, L.P.10% Owner
MXFMEXICO EQUITY & INCOME FUND INC
Open-market purchase
BUY$327K
16.0K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

30
BW
Booth Richard WhitakerSee Explanation of Responses
NONENONEFundrise Real Estate Interval Fund, LLC
Open-market purchase
BUY$500
42 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K